Eligible participants had confirmed stage I-IVA oesophageal carcinoma ( adenocarcinoma , squamous-cell , or adenosquamous ) , Eastern Cooperative Oncology Group ( ECOG ) status 0-2 , sufficient caloric intake , adequate haematological , renal , and hepatic function , and had been selected to receive definitive chemoradiotherapy .